touchCARDIO touchCARDIO
Arrhythmia
Read Time: 2 mins

189/Therapy withdrawal in patients with dilated cardiomyopathy and recovered cardiac function is not associated with an increased ventricular ectopic burden during exercise

Copy Link
Published Online: Oct 3rd 2008 European Journal of Arrhythmia & Electrophysiology. 2019;5(Suppl. 1):abstr189
Authors: B Grace (Presenting Author) – Royal Brompton Hospital, London, UK; R Jackson – Royal Brompton Hospital, London, UK; T Rahneva – Royal Brompton Hospital, London, UK; O Williams – Royal Brompton Hospital, London, UK; V Griffiths – Royal Brompton Hospital, London, UK; JGF Cleland – Royal Brompton Hospital, London, UK; SK Prasad – Royal Brompton Hospital, London, UK; BP Halliday – Royal Brompton Hospital, London, UK
Quick Links:
Article
Article Information
Article:

Background: Many dilated cardiomyopathy (DCM) patients have improvement in cardiac function with therapy. TRED-HF investigated the safety and feasibility of therapy withdrawal in such patients.

Methods: 45 participants from TRED-HF, (25 – control group and 20 – therapy withdrawal group), who had cardiopulmonary exercise testing (CPET) at baseline and follow-up were included (Figure 1). Change in VE burden (number of ventricular ectopic beats per minute) during exercise between baseline and follow-up was compared between groups in the randomised phase using the Mann-Whitney test. Twenty patients in the control group had therapy withdrawn in the cross-over phase with repeat CPET at follow-up. Change in VE burden amongst these patients was compared between the control and cross-over phases using the paired samples sign test. Correlation between change in VE burden and changes in left ventricular ejection fraction (LVEF), NT-pro-BNP and peak VO2 was examined using Spearman’s correlation. Baseline VE burden was compared amongst patients who had therapy withdrawal, based on the occurrence of the primary end-point.

Findings: There was no difference in change in VE burden during exercise between the control and treatment withdrawal groups in the randomised phase (median (IQR): 0·00 [-0·09:0·10] versus 0·00 [-0·64:0·03]; p=0·438) (Figure 1). There was no difference in change in VE burden amongst the control group in the randomised phase compared to the cross-over phase (median (IQR): 0·00 [-0·09:0·10] versus 0·00 [-0·11:0·02)]; p=0·581) (Figure 1). There was no significant association between change in VE burden and change in LVEF (rs=0·079, p=0·533), NT-pro-BNP (rs=0·101, p=0·425) and VO2 (rs=0·060, p=0·642). There was no difference in baseline VE burden between patients who relapsed and those who did not (p=0·539).

Interpretation: Therapy withdrawal in recovered DCM was not associated with an increased VE burden during exercise.

 

Further Resources

Share this Article
Related Content In Arrhythmia
  • Copied to clipboard!
    accredited arrow-down-editablearrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greenarrow-right-greyarrow-right-orangearrow-right-whitearrow-right-bluearrow-up-orangeavatarcalendarchevron-down consultant-pathologist-nurseconsultant-pathologistcrosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmdt_iconmenumore_dots nurse-consultantpadlock patient-advocate-pathologistpatient-consultantpatientperson pharmacist-nurseplay_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share single-doctor social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-red tick-whiteticktimetranscriptup-arrowwebinar Sponsored Department Location NEW TMM Corporate Services Icons-07NEW TMM Corporate Services Icons-08NEW TMM Corporate Services Icons-09NEW TMM Corporate Services Icons-10NEW TMM Corporate Services Icons-11NEW TMM Corporate Services Icons-12Salary £ TMM-Corp-Site-Icons-01TMM-Corp-Site-Icons-02TMM-Corp-Site-Icons-03TMM-Corp-Site-Icons-04TMM-Corp-Site-Icons-05TMM-Corp-Site-Icons-06TMM-Corp-Site-Icons-07TMM-Corp-Site-Icons-08TMM-Corp-Site-Icons-09TMM-Corp-Site-Icons-10TMM-Corp-Site-Icons-11TMM-Corp-Site-Icons-12TMM-Corp-Site-Icons-13TMM-Corp-Site-Icons-14TMM-Corp-Site-Icons-15TMM-Corp-Site-Icons-16TMM-Corp-Site-Icons-17TMM-Corp-Site-Icons-18TMM-Corp-Site-Icons-19TMM-Corp-Site-Icons-20TMM-Corp-Site-Icons-21TMM-Corp-Site-Icons-22TMM-Corp-Site-Icons-23TMM-Corp-Site-Icons-24TMM-Corp-Site-Icons-25TMM-Corp-Site-Icons-26TMM-Corp-Site-Icons-27TMM-Corp-Site-Icons-28TMM-Corp-Site-Icons-29TMM-Corp-Site-Icons-30TMM-Corp-Site-Icons-31TMM-Corp-Site-Icons-32TMM-Corp-Site-Icons-33TMM-Corp-Site-Icons-34TMM-Corp-Site-Icons-35TMM-Corp-Site-Icons-36TMM-Corp-Site-Icons-37TMM-Corp-Site-Icons-38TMM-Corp-Site-Icons-39TMM-Corp-Site-Icons-40TMM-Corp-Site-Icons-41TMM-Corp-Site-Icons-42TMM-Corp-Site-Icons-43TMM-Corp-Site-Icons-44TMM-Corp-Site-Icons-45TMM-Corp-Site-Icons-46TMM-Corp-Site-Icons-47TMM-Corp-Site-Icons-48TMM-Corp-Site-Icons-49TMM-Corp-Site-Icons-50TMM-Corp-Site-Icons-51TMM-Corp-Site-Icons-52TMM-Corp-Site-Icons-53TMM-Corp-Site-Icons-54TMM-Corp-Site-Icons-55TMM-Corp-Site-Icons-56TMM-Corp-Site-Icons-57TMM-Corp-Site-Icons-58TMM-Corp-Site-Icons-59TMM-Corp-Site-Icons-60TMM-Corp-Site-Icons-61TMM-Corp-Site-Icons-62TMM-Corp-Site-Icons-63TMM-Corp-Site-Icons-64TMM-Corp-Site-Icons-65TMM-Corp-Site-Icons-66TMM-Corp-Site-Icons-67TMM-Corp-Site-Icons-68TMM-Corp-Site-Icons-69TMM-Corp-Site-Icons-70TMM-Corp-Site-Icons-71TMM-Corp-Site-Icons-72